Perrigo Company plc (PRGO) has a MoatMap StockRank of 44/100 based on Quality (36/100), Value (68/100), and Momentum (27/100) factor scores. The current signal is HOLD. Perrigo is undergoing a complex turnaround in the highly competitive private-label OTC space. We strictly avoid turnarounds and low-margin commodity-like consumer products.
Perrigo Company plc is a global consumer self-care company specializing in the development, manufacture, and marketing of over-the-counter (OTC) health and wellness products, including leading store brand and generic medicines. The company holds a dominant market position in the store brand OTC sector across the United States and Europe, leveraging its extensive manufacturing capabilities and deep retail partnerships. Perrigo's strategy focuses on providing affordable, high-quality self-care solutions to a broad consumer base.
| Price | $10.46 |
| Market Cap | $1.6B |
| P/E (Forward) | 4.57 |
| Price/Book | 0.51 |
| Return on Equity | -52.2% |
| Return on Invested Capital | -15.1% |
| Debt/Equity | 153.22 |
| Gross Margin | 34.2% |
| Operating Margin | 3.5% |
| Revenue Growth | -7.2% |
| Dividend Yield | 10.7% |
| Free Cash Flow | $108M |
Perrigo Company plc operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Ireland).